191 related articles for article (PubMed ID: 18662199)
1. Results, rhetoric, and randomized trials: the case of donepezil.
Gilstad JR; Finucane TE
J Am Geriatr Soc; 2008 Aug; 56(8):1556-62. PubMed ID: 18662199
[TBL] [Abstract][Full Text] [Related]
2. Response to "Results, rhetoric, and randomized trials: the case of donepezil".
Lisi D
J Am Geriatr Soc; 2009 Jul; 57(7):1317-8; author reply 1318. PubMed ID: 19570171
[No Abstract] [Full Text] [Related]
3. Randomized clinical trial results for donepezil in Alzheimer's disease: is the treatment glass half full or half empty?
Farlow MR
J Am Geriatr Soc; 2008 Aug; 56(8):1566-7. PubMed ID: 18808602
[No Abstract] [Full Text] [Related]
4. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
Passmore AP; Bayer AJ; Steinhagen-Thiessen E
J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632
[TBL] [Abstract][Full Text] [Related]
5. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
Burns A; Gauthier S; Perdomo C
Int J Geriatr Psychiatry; 2007 Aug; 22(8):806-12. PubMed ID: 17199235
[TBL] [Abstract][Full Text] [Related]
7. Donepezil in the treatment of patients with Alzheimer's disease.
Tsuno N
Expert Rev Neurother; 2009 May; 9(5):591-8. PubMed ID: 19402770
[TBL] [Abstract][Full Text] [Related]
8. Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice?
Tinklenberg JR; Kraemer HC; Yaffe K; Ross L; Sheikh J; Ashford JW; Yesavage JA; Taylor JL
Am J Geriatr Psychiatry; 2007 Nov; 15(11):953-60. PubMed ID: 17974866
[TBL] [Abstract][Full Text] [Related]
9. The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: a Markov model.
Jönsson L; Lindgren P; Wimo A; Jönsson B; Winblad B
Clin Ther; 1999 Jul; 21(7):1230-40. PubMed ID: 10463520
[TBL] [Abstract][Full Text] [Related]
10. Donepezil in Alzheimer's disease: a clinical observational study evaluating individual treatment response.
Riepe MW; Kohler J; Horn R
Curr Med Res Opin; 2007 Aug; 23(8):1829-35. PubMed ID: 17599785
[TBL] [Abstract][Full Text] [Related]
11. How the FDA forgot the evidence: the case of donepezil 23 mg.
Schwartz LM; Woloshin S
BMJ; 2012 Mar; 344():e1086. PubMed ID: 22442352
[No Abstract] [Full Text] [Related]
12. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
[TBL] [Abstract][Full Text] [Related]
13. Donepezil for Alzheimer's disease.
Benjamin B; Burns A
Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of donepezil for mild to moderate Alzheimer's disease in Taiwan.
Fuh JL; Wang SJ
Int J Geriatr Psychiatry; 2008 Jan; 23(1):73-8. PubMed ID: 17520661
[TBL] [Abstract][Full Text] [Related]
15. [Relief for caregivers. Anti-dementia drug saves costs].
MMW Fortschr Med; 2001 Oct; 143(42):64. PubMed ID: 11697297
[No Abstract] [Full Text] [Related]
16. [Post-marketing observational study of donepezil].
Ibach B
Krankenpfl J; 2005; 43(1-3):25. PubMed ID: 15912820
[No Abstract] [Full Text] [Related]
17. Specific symptomatic changes following donepezil treatment of Alzheimer's disease: a multi-centre, primary care, open-label study.
Rockwood K; Black S; Bedard MA; Tran T; Lussier I;
Int J Geriatr Psychiatry; 2007 Apr; 22(4):312-9. PubMed ID: 17006874
[TBL] [Abstract][Full Text] [Related]
18. AD2000: donepezil in Alzheimer's disease.
Schneider LS
Lancet; 2004 Jun; 363(9427):2100-1. PubMed ID: 15220027
[No Abstract] [Full Text] [Related]
19. Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?
Stiles MM; Martin S; Persons RK
J Fam Pract; 2006 May; 55(5):435-6. PubMed ID: 16670040
[No Abstract] [Full Text] [Related]
20. Donepezil-induced nightmares in mild cognitive impairment.
Kitabayashi Y; Ueda H; Tsuchida H; Yamashita T; Narumoto J; Fukui K
Psychiatry Clin Neurosci; 2006 Feb; 60(1):123-4. PubMed ID: 16472374
[No Abstract] [Full Text] [Related]
[Next] [New Search]
